Sorteer per
Medicine and Dentistry
Immune Reconstitution
100%
Hematopoietic Cell
68%
B Cell
35%
Hazard Ratio
20%
Non-Relapse Mortality
20%
Natural Killer Cell
18%
Cell Transplantation
18%
CD8 Antigen
12%
T Cell
12%
Flow Cytometry
12%
Graft Versus Host Reaction
10%
Risk Stratification
10%
Hematologic Malignancy
8%
Acute Myeloid Leukemia
8%
Immunosuppressive Drug
6%
T-Helper Cell
6%
Infection
6%
Homeostasis
6%
Cancer
6%
Long Term Survival
6%
Cytotoxic T-Cell
6%
Immunocompetent Cell
6%
Disease
6%
Drug Exposure
6%
Quality of Life
6%
Keyphrases
Institutional Analysis
50%
Immune Reconstitution
50%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
50%
Recovery Monitoring
50%
B Cells
29%
Non-relapse Mortality
20%
CD4 Cells
20%
Confidence Interval
20%
Hazard Ratio
20%
CD-8
12%
Graft-versus-host Disease (GvHD)
12%
Natural Killer Cells
12%
Acute Myeloid Leukemia
8%
Hematological Malignancies
8%
Real-time Risk
7%
Clinical Trajectory
7%
Standardization Effort
7%
Immunology and Microbiology
Immune Reconstitution
100%
Hematopoietic Cell
68%
CD4
37%
B Cell
35%
Natural Killer Cell
18%
Cell Transplantation
18%
CD8
12%
T Cell
12%
Graft-Versus-Host Disease
10%
Myeloid
8%
Infection
6%
T-Helper Cell
6%
Drug Exposure
6%
Cytotoxic T-Cell
6%
Immunocompetent Cell
6%
Immunosuppressive Drug
6%
Long Term Survival
6%
Homeostasis
6%
